| Literature DB >> 29406974 |
Felicia A Scaggs Huang1, Elizabeth Schlaudecker2.
Abstract
Millions of children travel annually, whether they are refugees, international adoptees, visitors, or vacationers. Although most young travelers do well, many develop a febrile illness during or shortly after their trips. Approaching a fever in the returning traveler requires an appropriate index of suspicion to diagnose and treat in a timely manner. As many as 34% of patients with recent travel history are diagnosed with routine infections, but serious infections such as malaria, enteric fever, and dengue fever should be on the differential diagnosis due the high morbidity and mortality in children.Entities:
Keywords: Child; Fever; International travel; Returning traveler; Tropical infections
Mesh:
Year: 2018 PMID: 29406974 PMCID: PMC7135112 DOI: 10.1016/j.idc.2017.10.009
Source DB: PubMed Journal: Infect Dis Clin North Am ISSN: 0891-5520 Impact factor: 5.982
Patient history for the returning traveler with fever
| History | Implications |
|---|---|
| Travel itinerary | Offers information on potential diseases based on geography and other exposures |
| Diet history (improperly cooked meats, unpasteurized dairy products, seafood, or contaminated water and produce) | Brucellosis, |
| Sick contacts (both abroad and since returning to the US) | Routine viral or bacterial illnesses, Ebola infection, influenza, meningococcemia, tuberculosis |
| Fresh water exposure | Bacterial soft tissue infection ( |
| Sexual encounters | Acute human immunodeficiency virus (HIV) infection; gonorrhea; hepatitis A, B, or C infection; primary herpesvirus 1 or 2 infection; syphilis; Zika virus infection |
| Insect bites | Fleas: plague, murine typhus, rickettsioses Flies: African sleeping sickness, leishmaniasis, sandfly fever Lice: relapsing fever, rickettsioses Reduviid bugs: Chagas disease Mosquitoes: Chikungunya virus infection, dengue fever, filiarisis, Japanese encephalitis, West Nile virus infection, Zika virus infection Ticks: African tick bite fever, babesiosis, Lyme disease, Q fever rickettsioses, tularemia |
| Animal bites | Cat-scratch disease, rat bite fever, rabies, simian herpesvirus B infection |
| Animal exposure (including exposure to urine, stool, or animal products; eg, infected carcasses or wool) | Anthrax, avian influenza, hantavirus infection, Hendra virus infection, infections from ectoparasites or endoparasites, Nipah virus infection, plague, psittacosis, toxoplasmosis |
| Body fluid exposures (tattoos, piercings, or medical procedures) | Acute HIV infection, babesiosis, cytomegalovirus infection, hepatitis B and C, malaria, multidrug-resistant bacteria, trypanosomiasis |
| Medical history (diseases associated with immunosuppression; eg, malignancy, asplenia, or immunodeficiency) | Cytomegalovirus infection, Epstein-Barr virus infection, fungal infection, mycobacterial infections |
| Vaccinations and prophylaxis (note: these interventions do not preclude infection with the pathogen prophylaxed against) | Malaria prophylaxis, travel-appropriate vaccines |
Tropical causes of fever based on geography
| Location | Infection |
|---|---|
| Caribbean | Acute histoplasmosis, chikungunya, cholera, dengue fever, leptospirosis, malaria (Haiti, primarily |
| Central America | Acute histoplasmosis, coccidioidomycosis, dengue fever, hepatitis A and B, malaria (primarily |
| South America | Bartonellosis, dengue fever, malaria (primarily |
| South Central Asia | Dengue fever, enteric fever, hepatitis B, Japanese encephalitis, malaria (primarily non-falciparum |
| Southeast Asia | Chikungunya, cholera, dengue fever, hepatitis A, Japanese encephalitis, malaria (primarily non-falciparum |
| Sub-Saharan Africa | Acute schistosomiasis, enteric fever, filariasis, malaria (primarily |
Incubation period for common tropical diseases causing
| Disease | Incubation Period |
|---|---|
| Incubation of <14 d | |
| Acute HIV | 7–21 d |
| Arboviral infections (ie, chikungunya and Zika viruses) | 2–10 d |
| Dengue fever | 4–8 d |
| Enteric fever | 7–18 d |
| Leptospirosis | 7–12 d |
| Influenza | 1–3 d |
| Malaria | |
| | 6–30 d |
| | 8 d–12 mo |
| Rickettsioses | 3 d–3 wk |
| Incubation of 14 d to 6 wk | |
| Amebic liver abscess | Weeks–months |
| Hepatitis A | 28–30 d |
| Hepatitis B infection | 60–150 d |
| Rabies | Weeks–months |
| Schistosomiasis | 28–60 d |
| Tuberculosis | Weeks for primary infection |
| Visceral leishmaniasis | 2–10 mo |
Tropical diseases associated with fever
| Disease | Etiologic Pathogen | Geographic Regions | Vector or Exposure | Incubation Period | Presentation | Diagnosis | Management |
|---|---|---|---|---|---|---|---|
| Acute retroviral syndrome | HIV | Worldwide, highly prevalent in sub-Saharan Africa | Anal or vaginal sex, perinatal, needle stick, blood transfusion | 1–3 wk | Arthralgia, fever, rash, lymphadenopathy, pharyngitis | HIV-1 RNA, p24 antigen, immunoassay for HIV-1 and HIV-2 antibodies (preferred) | Antiretroviral therapy, consider trimethoprim-sulfamethoxazole prophylaxis |
| Anthrax | Central and South America, sub-Saharan Africa, Central and Southwestern Asia, Eastern Europe | Ingestion or handling of contaminated meat, playing drums from contaminated hides, contaminated heroin in drug users | Cutaneous: 1–17 d Gastrointestinal: 1–7 d Injection: 1–4 d Inhalation: 7–60 d | Varies with infection type; black eschar, cough, fever, nausea and vomiting, meningeal signs, severe soft tissue infection, shock | Bacterial culture, RT-PCR | Combination antimicrobial therapy | |
| Brucellosis | Central and South America, Africa, Middle East, Mediterranean basin, Eastern Europe | Unpasteurized dairy products, undercooked contaminated meat | 2–4 wk | Fever, headache, malaise, myalgias, night sweats, | Culture of sterile site (blood or bone marrow), PCR | Combination antimicrobial therapy | |
| Carrión’s disease (Oroya fever) | South America, especially Peru | Genus | 10–210 d | Fever, headache, myalgias, abdominal pain, anemia followed by nodular skin lesions | Bacterial culture | Antimicrobial therapy (aminoglycosides, tetracyclines, fluoroquinolones) | |
| Cat-scratch disease | Worldwide | Scratches from infected cats or kittens | 1–3 wk | Fever, lymphadenitis, follicular conjunctivitis, encephalitis | Culture, serologies, PCR | Usually self-limited, antimicrobials (macrolides) | |
| Chikungunya | Chikungunya virus | Africa, Asia, Central and South America, Pacific Islands | 3–7 d | Fever, arthritis, headache, conjunctivitis, maculopapular rash, myalgias | Virus-specific IgM, PCR | Supportive care, nonsteroidal antiinflammatory drugs for joint pain | |
| Ebola & Marburg virus diseases | Ebola virus & Marburg virus | Africa | Body fluids | 2–21 d | Prodrome of fever, arthralgias, headache, myalgias followed by conjunctivitis, coagulopathy, profuse diarrhea, shock | Antigen detection, RT-PCR, serologies | Experimental immune therapies & antivirals, supportive care |
| Endemic typhus | Worldwide, especially Southeast Asia | Rodent fleas (eg, | 7–14 d | Fever, headache, malaise, nausea and vomiting, rash | IgM and IgG ELISA, PCR | Antimicrobial therapy (chloramphenicol, doxycycline) | |
| Epidemic typhus | Central Africa, Asia, Central and South America | 7–14 d | Fever, headache, malaise, nausea and vomiting, rash | IgM and IgG ELISA, PCR | Antimicrobial therapy (doxycycline) | ||
| Japanese encephalitis | Japanese encephalitis virus | Asia, Western Pacific | 5–15 d | Febrile illness, aseptic meningitis, acute encephalitis | IgM ELISA | Supportive care | |
| Lassa fever and other arenaviral infections | Argentine hemorrhagic fever, Lassa virus, Lujo virus, LCMV | Africa, Asia, Europe, North America, and South America | Rodent urine and feces | 2–21 d | Fever, myalgia, arthralgia, headache, meningeal signs, retrosternal pain, coagulopathy, birth defects (Lassa and LCMV) | Cell culture, IgM ELISA, RT-PCR | Antimicrobial therapy (ribavirin for Lassa fever), supportive care |
| Leptospirosis | Caribbean, sub-Saharan Africa, South America, Southeast Asia | Infected animal body fluid or urine, contaminated water, food, or soil | 2–30 d | Fever, conjunctival suffusion, back pain, rash, diarrhea, vomiting, renal and liver failure | IgM and IgG ELISA, PCR | Antimicrobial therapy (penicillins, doxycycline) | |
| Lyme disease | Europe, Northern to Central Asia | 3–30 d | Fever, cranial nerve palsy, erythema migrans, headache, malaise, myalgia, myocarditis, meningitis | 2-tiered serologic testing (ELISA or IFA & Western blot) | Antimicrobial therapy (beta-lactams, doxycycline) | ||
| Murray Valley encephalitis | Murray Valley encephalitis virus | New Guinea, Northwestern or southeastern Australia | 7–28 d | Fever, meningeal signs, seizures | IgM ELISA, neutralizing antibodies, RT-PCR | Supportive care | |
| Plague | Central and Southern Africa, Central Asia, Northeastern South America | 1–6 d | Varies with infection type; fever, lymphadenitis, overwhelming pneumonia, sepsis with gangrene | Culture, serologies | Antimicrobial therapy (aminoglycoside, fluoroquinolone, tetracyclines) | ||
| Poliomyelitis | Enterovirus types 1,2,3 | Sub-Saharan Africa, Middle East, South and Southeast Asia | Fecal-oral | 7–21 d | Flaccid paralysis, respiratory failure | Cell culture, NAAT, PCR | Supportive care |
| Q fever | Africa, Middle East, Europe | Aerosolized birth fluids or feces from infected livestock | 2–3 wk | Self-limiting respiratory illness, pneumonia, hepatitis, cardiac disease | Serial IgG IFA, PCR | Antimicrobial therapy (doxycycline, trimethoprim-sulfamethoxazole, fluoroquinolones) | |
| Rabies | Rabies virus | Africa, Asia, Central and South America | Saliva from infected animal bite (especially bats) | Weeks–months | Prodrome of fever, pain, paresthesias followed by hydrophobia, delirium, seizures, death | Neutralizing antibodies, RT-PCR, IFA | Supportive care, experimental Milwaukee protocol |
| Rat lungworm | Caribbean, Asia, Pacific islands | Ingestion of infected snails & slugs or contaminated produce | 1–3 wk | Fever, meningeal signs, paresthesias | Serum antibodies, PCR | Supportive care | |
| Relapsing fever | Sub-Saharan Africa | 4–14 d | Fever, headache, myalgia, arthralgia, rash | Microscopic evaluation of blood smear, IgM and IgG ELISA, PCR | Antimicrobial therapy (doxycycline) | ||
| Rickettsioses | Genera | Africa, Europe, India, and Middle East | Ectoparasites (fleas, lice, mites and ticks) | 7–14 d | Fever, headache, eschar ( | Clinical diagnosis, PCR, serologies, biopsy of eschar | Antimicrobial therapy (doxycycline) |
| RVF and other bunyaviral infections | RVF virus, CCHF, hantavirus | Africa, Eurasia, Middle East, North and South America | 2–21 d | Fever, myalgia, arthralgia, headache, meningeal signs, vision loss (RVF), coagulopathy, renal failure (hantavirus), ecchymoses (CCHF) | Cell culture, IgM ELISA, RT-PCR | Antimicrobial therapy (ribavirin for CCHF), supportive care | |
| Rubella | Rubella virus | Africa, Middle East, South and Southeast Asia | Person-to-person and droplet | 14 d | Fever, conjunctivitis, lymphadenopathy, rash; congenital defects | Serologies, RT-PCR | Supportive care |
| Scrub typhus | Asia, Pacific regions | Larval mite (chigger) | 6–20 d | Fever, headache, malaise, nausea and vomiting, rash | IgM and IgG ELISA, PCR | Antimicrobial therapy (chloramphenicol, doxycycline) | |
| Sleeping sickness | Sub-Saharan, Central, and Western Africa | 7–21 d | Fever, chancre at bite site, splenomegaly, renal failure, sleep cycle disruption | Microscopic examination of sterile sites or chancre-tissue biopsy | Antimicrobial therapy (suramin for early stage, eflornithine & nifurtimox for late stage) | ||
| Tetanus | Worldwide, most common rurally | Contaminated wounds with dirt, excrement; punctures | 10 d | Cranial nerve palsies, muscle spasms and rigidity, respiratory failure | Clinical diagnosis | Human tetanus immune globulin, tetanus toxoid, supportive care | |
| Tick-borne encephalitis | Tick-borne encephalitis virus | Central and Eastern Europe and Northern Asia | 4–28 d | Prodrome of febrile illness followed by aseptic meningitis, encephalitis, myelitis | IgM ELISA, RT-PCR | Supportive care | |
| Toxoplasmosis | Worldwide | Ingestion of undercooked meat or contaminated water, cat feces | 5–23 d | Fever, lymphadenopathy, chorioretinitis, encephalitis or pneumonitis if immunocompromised; congenital syndrome | Serologies, ocular examination, computed tomography or MRI for intracranial lesions | Supportive care or antimicrobial therapy (pyrimethamine, sulfadiazine, leucovorin) | |
| Yellow fever | Yellow fever virus | Sub-Saharan Africa, South America | 3–6 d | Fever, headache, back pain, nausea, vomiting, coagulopathy, shock | RT-PCR, IgM ELISA | Supportive care | |
| Zika | Zika virus | Africa, Asia, South and Central America | 3–12 d | Fever, arthralgia, conjunctivitis, headache, rash; congenital syndrome | RT-PCR, serologies | Supportive care |
Abbreviations: CCHF, Crimean-Congo hemorrhagic fever; ELISA, enzyme-linked immunoassay; Ig, immunoglobulin; IFA, immunofluorescence assay; LCMV, lymphocytic choriomeningitis; NAAT, nucleic acid amplification test; PCR, polymerase chain reaction; RT-PCR, real-time polymerase chain reaction; RVF; Rift Valley fever.
Tropical diseases associated with gastrointestinal symptoms
| Disease | Etiologic Pathogen | Geographic Regions | Vector or Exposure | Incubation Period | Presentation | Diagnosis | Management |
|---|---|---|---|---|---|---|---|
| amebiasis | Worldwide | Fecal-oral, contaminated food or water | Days–weeks | Abdominal cramps, watery or bloody diarrhea, weight loss, liver abscess with abdominal pain | Microscopic evaluation of stool, serologies | Antimicrobial therapy (metronidazole + iodoquinol or puromycin) | |
| Campylobacteriosis | Worldwide | Contaminated foods (raw poultry) and water, unpasteurized milk, fecal-oral | 2–4 d | Abdominal pain, fever, bloody diarrhea, nausea and vomiting, pseudoappendicitis, reactive arthritis, Guillain-Barre syndrome | Stool culture, darkfield microscopy, NAAT | Supportive care, antimicrobial therapies (fluoroquinolone, macrolide) | |
| Chagas disease | Central and South America | Reduviid bug, contaminated food or water, blood transfusion | 7 d | Chagoma (eg, Romaña sign), ventricular arrhythmias, megacolon, megaesophagus | Microscopic evaluation of blood smear, IgM ELISA, PCR (acute disease only) | Antimicrobial therapy (benznidazole, nifurtimox) | |
| Cholera | Africa, Caribbean, Southeast Asia | Aquatic plants, brackish water, shellfish | 5 d | Profuse, watery diarrhea, nausea and vomiting, muscle cramps, hypovolemic shock | Stool culture | Supportive care, antimicrobial therapy (azithromycin, doxycycline) | |
| Cyclosporiasis | Worldwide | Contaminated produce and water | 2–14 d | Watery diarrhea, anorexia, weight loss, abdominal cramps, myalgias, vomiting | Microscopic evaluation of stool for oocysts | Antimicrobial therapy (trimethoprim-sulfamethoxazole) | |
| Echinococcosis | Eurasia, Central and South America, Africa | Contaminated dog feces, contaminated food or water | 5–15 y | Hydatid cysts in liver and lungs, abdominal pain, liver failure | Imaging (ultrasound, computed tomography scan), serologies | Supportive care, surgical excision if cyst >10 cm, antimicrobial therapy (albendazole, praziquantel) | |
| Traveler’s diarrhea | Enterotoxigenic | Worldwide | Fecal-oral, contaminated food or water | 9 h–3 d | Abdominal pain, watery diarrhea | Clinical diagnosis, NAAT | Supportive care, antimicrobial therapy (ciprofloxacin, azithromycin) |
| Fascioliasis | South America, Middle East, Southeast Asia | Watercress or other aquatic plants, freshwater | 6–12 wk | Intermittent, fever eosinophilia, abdominal pain, weight loss, urticaria, biliary colic, liver failure | Microscopic evaluation of stool, serologies, liver imaging | Antimicrobial therapy (triclabendazole) | |
| Giardiasis | Worldwide | Fecal-oral, sexual contact, contaminated water | 1–2 wk | Abdominal pain, anorexia, foul-smelling diarrhea, flatulence, nausea, reactive arthritis | Microscopic evaluation of stool, DFA | Antimicrobial therapy (metronidazole, tinidazole, nitazoxanide) | |
| Peptic ulcer disease | Worldwide | Fecal-oral, oral-oral | Unknown | Epigastric pain, nausea and vomiting, anorexia, gastric cancer | Fecal antigen assay, urea breath test | Antimicrobial therapy (proton pump inhibitor + clarithromycin + amoxicillin) | |
| Pinworm | Worldwide | Fecal-oral, contaminated objects | 1–2 mo | Perianal pruritus | Scotch tape test, microscopic evaluation of fingernails | Antimicrobial therapy (albendazole, pyrantel pamoate) | |
| Sarcocystosis | Worldwide, especially Southeast Asia | Undercooked beef or pork | 2 wk | Fever, malaise, myalgia, headache, cough, arthralgia, nausea and vomiting, diarrhea, palpitations | Microscopic evaluation of stool, PCR, muscle biopsy | Antimicrobial therapy (trimethoprim-sulfamethoxazole) | |
| Soil-transmitted helminths | Worldwide | Fecal-oral, skin penetration with contaminated soil (hookworms) | Variable | Abdominal pain, malnutrition, bowel obstruction, anemia, cough, chest pain | Microscopic evaluation of stool | Antimicrobial therapy (albendazole, mebendazole) | |
| Strongyloidiasis | Worldwide | Auto-inoculation, skin penetration | Variable | Pruritic rash at penetration site, serpiginous rashes (larva currens), respiratory symptoms (Löffler-like pneumonitis), abdominal pain, diarrhea, severe disease if immuno-compromised | Microscopic evaluation of stool other body fluids if disseminated (eg, sputum, CSF) | Antimicrobial therapy (ivermectin, albendazole) | |
| Taeniasis | Central and South America, Africa, South and Southeast Asia | Undercooked contaminated pork or beef | 8–10 wk for | Abdominal discomfort, weight loss, anorexia, perianal pruritus, insomnia, weakness | Microscopic evaluation of stool for eggs | Antimicrobial therapy (praziquantel, niclosamide unless symptomatic neurocysticercosis) | |
| Visceral leishmaniasis | South America, Central and Southwest Asia, East Africa | Phlebotomine sand fly, blood transfusions | Weeks–months | Fever, weight loss, hepatosplenomegaly, pancytopenia | Light-microscopic evaluation of specimens, culture, molecular methods | Antimicrobial therapy (amphotericin B, miltefosine) | |
| Yersiniosis | Japan, Northern Europe | Undercooked contaminated pork, contaminated water, unpasteurized dairy | 4–6 d | Fever, abdominal pain (pseudoappendicitis), bloody diarrhea, necrotizing enterocolitis in infants, reactive arthritis, erythema nodosum | Stool culture (or other body sits; eg, CSF, blood) | Supportive care, antimicrobial therapy if severe (trimethoprim-sulfamethoxazole, fluoroquinolones, aminoglycosides) |
Abbreviations: CSF, cerebrospinal fluid; DFA, direct fluorescent antibody.
Tropical diseases associated with respiratory symptoms
| Disease | Etiologic Pathogen | Geographic Regions | Vector or Exposure | Incubation Period | Presentation | Diagnosis | Management |
|---|---|---|---|---|---|---|---|
| Avian bird flu | H5N1 and H7N9 influenza A virus | East and Southeast Asia | Poultry | 2–8 d | Fever, malaise, myalgia, headache, nasal congestion, cough, acute respiratory distress syndrome (ARDS) | RT-PCR | Supportive care |
| Diphtheria | Asia, South Pacific, Middle East, Eastern Europe, Caribbean | Person-to-person (oral or respiratory droplets), fomites | 2–5 d | Fever, dysphagia, malaise, anorexia, pseudomembranes | Bacterial culture | Supportive care, equine diphtheria antitoxin (DAT), antimicrobial therapy (erythromycin, penicillin) | |
| Coccidioidomycosis | Central and South America | Inhalation of spores from soil | 7–21 d | Fever, malaise, cough, headache, night sweats, myalgias, arthritis, rash | Culture, IgM and IgG ELISA, immunodiffusion and complement fixation | Supportive care, antimicrobial therapy if ill or at high risk of dissemination (amphotericin B, azoles) | |
| Histoplasmosis | Worldwide, especially river valleys | Inhalation of spores from soil, bird droppings, bat guano | 3–17 d | Fever, headache, cough, pleuritic chest pain, malaise | Culture, microscopic examination, PCR, EIA on serum or other samples, immunodiffusion complement fixation | Supportive care, antimicrobial therapy (azole for mild to moderate disease, amphotericin B for severe) | |
| Legionellosis (Legionnaire’s disease and Pontiac fever) | Worldwide | Inhalation of freshwater aerosol | 2–10 d | Fever, headache, myalgias, pneumonia, respiratory distress | Urine antigen assay, paired serologies, PCR | Antimicrobial therapy (fluoroquinolones, macrolides) | |
| Melioidosis | Central and Southeast Asia, northern Australia, South America | Subcutaneous inoculation, inhalation, ingestion; body fluids | 1–21 d | Fever, cough, weight loss, pneumonia | Culture, indirect hemagglutination assay | Antimicrobial therapy (ceftazidime, meropenem) | |
| Middle Eastern Respiratory Syndrome (MERS) | MERS coronavirus | North Africa, Middle East | Dromedary camel, person-to-person | 2–14 d | Fever, cough, arthralgia, diarrhea, myalgia, acute respiratory failure, multiple organ dysfunction | RT-PCR | Supportive care |
| Pertussis (whooping cough) | Worldwide | Person-to-person (aerosolized respiratory droplets, respiratory secretions) | 7–10 d | Paroxysmal cough, post-tussive vomiting, apnea in infants | Culture, serologies, PCR | Antimicrobial therapy (macrolides) |
Tropical diseases associated with dermatologic symptoms
| Disease | Etiologic Pathogen | Geographic Regions | Vector or Exposure | Incubation Period | Presentation | Diagnosis | Management |
|---|---|---|---|---|---|---|---|
| B virus | Worldwide | Bites, scratches, body fluids of infected macaque | 3–30 d | Fever, headache, myalgias, vesicular lesions near exposure site with neuropathic pain, ascending encephalomyelitis | PCR, virus-specific antibodies | Supportive care, postexposure prophylaxis (valacyclovir), antimicrobial therapy (acyclovir, ganciclovir) | |
| Cutaneous leishmaniasis | Middle East, Southwest and Central Asia, North Africa, Southern Europe, Central and South America | Phlebotomine sand fly | Weeks–months | Papules that progress to ulcerated plaques, regional lymphadenopathy, and nodular lymphangitis | Light-microscopy evaluation of specimens, cultures, molecular methods | Antimicrobial therapy (miltefosine, amphotericin B) | |
| Cutaneous larva migrans | Caribbean, Africa, Asia, South America | Skin contact with contaminated sand | 1–5 d | Serpiginous track on skin with pruritus and edema | Clinical | Supportive care, antimicrobial therapy if desired (albendazole, ivermectin) | |
| Loiasis (African eye worm) | Central and West Africa | Genus | 7–12 d | Localized edema of extremities and joints (Calabar swelling), diffuse pruritus, eye pruritus and pain, and photophobia | Microscopic evaluation of adult worm from eye, microscopic evaluation of microfilariae on blood smear, serologies | Surgical excision of adult worms, antimicrobial therapy (diethylcarbamazine, albendazole) | |
| Lymphatic filariasis | Sub-Saharan Africa, Southern Asia, Pacific Islands, South America, Caribbean | Years | Lymphatic dysfunction with affected limb edema and pain | Microscopic evaluation of peripheral blood smear, serologies | Antimicrobial therapy (diethylcarbamazine, doxycycline) | ||
| Myiasis | Maggots of | Central and South America, Africa, Caribbean | Bites of infected flies or egg laying on open wounds | 1–2 wk | Localized skin nodule, pruritus, discharge from punctum | Clinical, serologies | Surgical excision of larvae |
| Rat-bite fever | Worldwide | Bites, scratches, oral secretions of infected rats; unpasteurized milk or contaminated food or water | 7–21 d | Relapsing fever, maculopapular or purpuric rash, migratory polyarthritis, lymphadenopathy | Culture, darkfield microscopy, stained peripheral blood smear | Antimicrobial therapy (penicillin G) | |
| River blindness (onchocerciasis) | Sub-Saharan Africa, Middle East, South | Genus | Weeks –years | Pruritic, popular rash with subcutaneous nodules, lymphadenitis, ocular lesions, vision loss | Microscopic evaluation of skin shavings with microfilariae, histologic evaluation, serologies | Antimicrobial therapy (ivermectin + doxycycline) | |
| Scabies | Worldwide | Prolonged skin-to-skin contact, fomites if crusted scabies | 2–6 wk | Nocturnal pruritus, papulovesicular rash, crusts and scales if crusted scabies | Microscopic evaluation of skin scraping | Antimicrobial therapy (permethrin, ivermectin creams) | |
| Strongyloidiasis | Worldwide | Skin penetration with contaminated soil | Unknown | Localized, pruritic, erythematous popular rash, pulmonary symptoms (Löffler-like pneumonitis), diarrhea, abdominal pain, eosinophilia, serpiginous urticarial rash (larva currens) | Microscopic evaluation of stool, peripheral blood eosinophilia if disseminated, serologies | Antimicrobial therapy (ivermectin, albendazole) | |
| Tungiasis | Africa, South America | Skin penetration (especially walking barefoot) | 1–2 d | Localized pruritus and pain with lesions and ulcerations with central black dot | Clinical | Extraction of flea using sterile needle |